AMCR vs CARL · P/E 18, rev $23.51B vs rev $50.5M
Amcor PLC (AMCR) versus Carlsmed, Inc. Common Stock (CARL) — a side-by-side from cached financials, not a winner call.
Amcor PLC (AMCR) is a packaging & containers company listed on US.
Carlsmed, Inc. Common Stock (CARL) is a health information services company listed on NASDAQ.
Latest reported AMCR revenue for 2026-06-30 was $23.51B. Net income was $1.11B. Revenue was up 362.5% from 2025-06-30 to 2026-06-30. AMCR currently screens at market cap $22.52B and trailing P/E 17.6.
Latest reported CARL revenue for 2025-12-31 was $50.5M. Net income was -$29.6M. Revenue was up 85.9% from 2024-12-31 to 2025-12-31. CARL currently screens at market cap $299.7M.
AMCR currently screens at market cap $22.52B and trailing P/E 17.6. CARL currently screens at market cap $299.7M.
Not investment advice. Open the AMCR and CARL stock pages for the full models.
Not investment advice.